ClinicalTrials.Veeva

Menu

Mechanistic Studies of Chronic COPD Using Single-Cell Sequencing and Single-Cell Spatial Transcriptomics

T

Tongji University

Status

Not yet enrolling

Conditions

COPD

Study type

Observational

Funder types

Other

Identifiers

NCT07208123
HSCRNACOPD-001

Details and patient eligibility

About

This study is an ambispective cohort study, the sample from patients were from both previously stored and freshly collected . The objective of this study is to investigate the molecular pathological changes underlying the development of chronic obstructive pulmonary disease (COPD). We will use single cell sequencing technology to analyze lung tissue samples from patients who underwent lung resection, with lung tissue from patients without COPD serving as controls. This research aims to provide insights into the pathogenesis of COPD.

Enrollment

150 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Receiving lung resection surgery at the hospital for any reason;
  • Diagnosed with COPD according to the 2024 GOLD guidelines;
  • Tissue samples that meet collection requirements and are either agreed to be collected or already preserved;

Exclusion criteria

  • Improper preservation of pathological specimens, refusal to consent to sample collection, or incomplete clinical information;
  • Combined with other factors causing obstructive airflow limitation;
  • Diagnosed with asthma according to the GINA 2023 guidelines and with a history of asthma exacerbations within the past year;
  • Combined with Advanced lung cancer;
  • Receiving systemic immunosuppressive medications such as anti-rejection drugs;

Trial design

150 participants in 1 patient group

COPD group

Trial contacts and locations

1

Loading...

Central trial contact

Feng Xinyu, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems